Business Description
The Cooper Companies Inc
NAICS : 339115
SIC : 3851
ISIN : US2166484020
Share Class Description:
MEX:COO: Ordinary SharesTotal Employee Number:
15,000Description
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.3 | |||||
Debt-to-EBITDA | 2.76 | |||||
Interest Coverage | 5.35 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.34 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.1 | |||||
3-Year EBITDA Growth Rate | 5.7 | |||||
3-Year EPS without NRI Growth Rate | 10 | |||||
3-Year FCF Growth Rate | -1.4 | |||||
3-Year Book Growth Rate | 5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.42 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 5.07 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.72 | |||||
9-Day RSI | 94.35 | |||||
14-Day RSI | 81.75 | |||||
3-1 Month Momentum % | -15.91 | |||||
6-1 Month Momentum % | -27.93 | |||||
12-1 Month Momentum % | -21.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.27 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 219.37 | |||||
Days Sales Outstanding | 69.33 | |||||
Days Payable | 63.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 3.3 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 65.55 | |||||
Operating Margin % | 11.77 | |||||
Net Margin % | 5.57 | |||||
EBITDA Margin % | 21.04 | |||||
FCF Margin % | 13.51 | |||||
OCF Margin % | 22.58 | |||||
ROE % | 2.84 | |||||
ROA % | 1.9 | |||||
ROIC % | 2.38 | |||||
3-Year ROIIC % | 4.54 | |||||
ROC (Joel Greenblatt) % | 16.55 | |||||
ROCE % | 4.55 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 60.19 | |||||
Forward PE Ratio | 14.45 | |||||
PE Ratio without NRI | 15.57 | |||||
Shiller PE Ratio | 19.79 | |||||
Price-to-Owner-Earnings | 28.94 | |||||
PEG Ratio | 1.44 | |||||
PS Ratio | 3.31 | |||||
PB Ratio | 1.68 | |||||
Price-to-Tangible-Book | 4.85 | |||||
Price-to-Free-Cash-Flow | 24.66 | |||||
Price-to-Operating-Cash-Flow | 14.73 | |||||
EV-to-EBIT | 31.99 | |||||
EV-to-Forward-EBIT | 28.98 | |||||
EV-to-EBITDA | 18.17 | |||||
EV-to-Forward-EBITDA | 17.45 | |||||
EV-to-Revenue | 3.82 | |||||
EV-to-Forward-Revenue | 3.76 | |||||
EV-to-FCF | 28.4 | |||||
Price-to-GF-Value | 0.7 | |||||
Price-to-Projected-FCF | 1.24 | |||||
Price-to-DCF (Earnings Based) | 1.09 | |||||
Price-to-DCF (FCF Based) | 1.93 | |||||
Price-to-Median-PS-Value | 0.62 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.41 | |||||
Price-to-Graham-Number | 1.83 | |||||
Earnings Yield (Greenblatt) % | 3.13 | |||||
FCF Yield % | 4.11 | |||||
Forward Rate of Return (Yacktman) % | 9.26 |
The Cooper Companies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
The Cooper Companies Inc Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2026-12-04 17:00 | In 159 days | ||
| Fourth quarter earnings results for 2026 | 2026-12-04 16:15 | In 159 days | ||
| Annual report for 2026 | 2026-12-04 | In 158 days | ||
| Third quarter earnings conference call for 2026 | 2026-08-27 17:00 | In 60 days | ||
| Third quarter earnings results for 2026 | 2026-08-27 16:15 | In 60 days | ||
| Second quarter earnings conference call for 2026 | 2026-06-04 17:00 | 1,069.00 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-06-04 16:15 | 1,069.00 (+0.00%) | ||
| General meeting for 2026 | 2026-04-07 08:00 | 1,251.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-03-05 17:00 | 1,415.95 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-03-05 16:15 | 1,415.95 (+0.00%) |
Show
Entries
Press Release
Articles on The Cooper Companies Inc
No articles.